BioKier initiated a clinical trial of BKR-013 colon-targeted capsules in collaboration with Pennington Biomedical Research Center, Baton Rouge, LA. This study will examine the Effect of BKR-013 on Average Daily Glucose Levels.
This trial is registered on www.ClinicalTrials.gov with identifier: NCT03382015, please follow this link for more information. Subject recruitment was initiated January, 2018.